# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 54: Amendment to regulation 66

Extent: E+W+S+N.I.

In regulation 66(2) (application for renewal of authorisation)—
(a) for sub-paragraph (a) substitute—
“(a) a UK marketing authorisation, must, subject to sub-paragraph (b), be established in the UK or an EEA State; and”;
(b) in sub-paragraph (b)—
(i) for “UKMA(GB)” substitute “UKMA(UK)(Category 2)”;
(ii) omit paragraph (ii);
(c) omit sub-paragraph (c).

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/54 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-54
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.